Category Archives: U.S. Policy and Funding

Thinking strategically about nutrition supports disease responses and more

By on .

The following is a guest post by Heather B. Davis, MPH, and Emily A. Bobrow, PhD, MPH, of MEASURE Evaluation Who has a strategic interest in nutrition? Is the world on course to meet global nutrition targets? What does it mean to have a robust national dialogue to support the development of practical nutrition solutions? […]

With TB now No. 1 global infectious disease killer, USAID justifies cuts to global TB funding

By on .

When House Appropriations Committee members in 2014 asked then USAID Administrator Raj Shah how the U.S. could combat tuberculosis globally with 19 percent less money, he said not to worry. The Global Fund to Fight AIDS, TB and Malaria, and the President’s Emergency Plan for AIDS Relief would fill the gap, he said. Two years […]

While HIV aid drops, overall global health spending shows “enduring support”

By on .

While development assistance to middle and low-income countries for global health reached an all-time high last year, assistance for “the main infectious diseases, HIV/AIDS, tuberculosis, and malaria, contracted on the whole,” according to the Financing Global Health 2013: Transition in an Age of Austerity report published by the Institute of Health Metrics and Evaluation. Total […]

Keeping up with the Global Fund

By on .

After a tumultuous few years the Global Fund to Fight AIDS, Tuberculosis and Malaria is nearing completion of, at least, the first phases of a makeover, with the framework for a new funding model agreed upon at its September board meeting, and details of the model to be decided at the next, Nov. 14-15 board […]

TB advocates respond to Global Fund proposal for “historical disease allocation” model

By on .

As board members of the Global Fund to Fight AIDS, Tuberculosis and Malaria prepare to meet Thursday and Friday in Geneva, advocates for tuberculosis detection, treatment and prevention have signed a response to a proposal they say will foster a divisive “disease against disease” approach to funding, and seriously undermine efforts to roll out cost-effective […]

New vaccine would revolutionize the fight against tuberculosis…if funding is available

By on .

How could the world dramatically lower the incidence of tuberculosis and save millions of lives?  An effective TB vaccine would revolutionize the response to TB, which kills about 5000 people each day, and eliminate the need for lengthy and often difficult drug treatment.    An effective vaccine would be of tremendous benefit all over the world, including […]